期刊文献+

CD105和VEGF、TGF-B1在结直肠癌的表达及其与浸润、转移和血管生成的关系 被引量:7

Expression of CD105,VEGF and TGF-β1 in colorectal cancer and their relationship to invasion,metastasis and angiogenesis
下载PDF
导出
摘要 目的探讨结直肠癌中CD 105和VEGF、TGF-β1的表达及与血管生成的关系。方法应用免疫组化方法检测60例结直肠癌中CD 105标记的微血管密度(M VD)和VEGF、TGF-β1的表达。结果60例结直肠癌中CD 105表达的M VD为36.50±9.43。VEGF、TGF-β1表达的阳性率为68.3%,75.0%。M VD和VEGF、TGF-β1表达与肿瘤浸润深度、淋巴结转移和Dukes分期密切相关(P<0.05)。VEGF、TGF-β1表达均与M VD呈正相关(P<0.01),TGF-β1与VEGF也呈正相关(P<0.05)。结论CD 105、VEGF、TGF-β1关系密切,三者联合检测可作为结直肠癌新生血管和浸润转移的有价值的标志物。 Objective To study the expression of CD105,VEGF and TGF-β1 in colorectal cancer and their relationship with angiogenesis. Methods Immunohistochemical staining (S-P method) for VEGF, TGF-β1 and microvessel density (MVD) with marked CD105 were performed in 60 cases of colorectal cancer. Results The value of MVD with marked CD105 was 36.50±9.43 in colorectal cancer. The positive rates of VEGF and TGF-β1 were 68.30/00 and 75.0% ,respectively. The value of MVD and the expression of VEGF and TGF-β1 were significantly correlated to the tumor depth of invasion, lymphonode metastasis and Dukes stages (P〈0.05). The expression of VEGF and TGF-β1 was positively correlated to MVD (P〈0.01). There was a significant positive correlation between the expressions of TGF-β1 and VEGF(P〈0.05). Conclusion CD105, VEGF and TGF-β1 are closely correlated,which may be valuable markers in evaluating the angiogenesis,invasion and metastasis in colorectal cancer when combined.
出处 《实用肿瘤杂志》 CAS 2006年第5期421-424,共4页 Journal of Practical Oncology
关键词 结肠直肠肿瘤 CD105 血管内皮生长因子 TGF-Β1 微血管密度 免疫组织化学 colorectal neoplasms CD105 vascular endothelial growth factor TGF-β1 microvessel density immunohistochemistry
  • 相关文献

参考文献10

  • 1Folkman J.Clinical applications of research on angiogenesis[J].N Engl J Med,1995,333(26):1757-1783.
  • 2Weindener N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indication in early-stage breast carcinoma[J].J Natl Cancer Inst,1992,84(24):1875-1887.
  • 3Miller DW,Graulich W,Karges B,et al.Elevated expression of endoglin a component of the TGF-beta-receptor complex,correlates with proliferation of tumor endothelial cells[J].Int J Cancer,1999,81(4):568-572.
  • 4Li DY,Sorensen LK,Broke BS,et al.Defective angiogenesis in mice lacking endoglin[J].Science,1999,284 (5419):1534-1537.
  • 5Takebayashi Y,Aklyama S,Yamada K,et al.Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma[L].Cancer,1996,78(2)226-231.
  • 6Tanigawa N,Amaya H,Mastumura M,et al.Tumor angiogenesis and mode of metastasis in patients with colorectal cancer[J].Caner Res,1997,57(6):1043-1046.
  • 7Arii S,Mori A,Uchida S,et al.Implication of vascular endothelial growth factor in the development and matastasis of human cancer[J].Hum Cell,1999,12(1):25-30.
  • 8李洪燕,陈晓光.转化生长因子β与肿瘤研究进展[J].国外医学(肿瘤学分册),2002,29(1):17-20. 被引量:17
  • 9Ishigami SI,Arii S,Furatani M,et al.Predictive value of vascular endothelial growth factor (VEGF)in metastasis and prognosis of human colorectal cancer[J].Br J Cancer,1998,78(10):1379-1384.
  • 10Bellone G,Carbone A,Tibaudi D,et al.Differential expression of transforming growth factor-beta 1,-beta 2,-beta 3 in human colon carcinoma[J].Eur J Cancer,2001,37(2):224-233.

二级参考文献23

  • 1Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor in human disease[J]. N Engl J Med, 2000, 342(18): 1350-1358.
  • 2Imamura T, et al. Smad6 inhibits signaling by the TGF-β superfamily[J]. Nature, 1997, 389 (6651): 622-626.
  • 3Nakao A, Takase M, Nishihara A, etal. Identifieation of Smad7, a TGF-β-inducible antagonist of TGF-β-signaling [J]. Nature, 1997, 389(6651): 631-635.
  • 4Yoo YD, Choi JY, Lee SJ, et al. TGF-beta-induced cell-cycle arrest through the p21 (WAF1/C1P1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells[J]. Int J Cancer, 1999, 83(4): 512-517.
  • 5Lavarone A , Massague J. Repression of CDK activitor edc25A and cell-cycle arrest by cytokine TGF-β cells in lacking CDK inhibitor p15[J]. Nature, 1997, 387(6631): 417-422.
  • 6Grady WM., Myeroff LL, Swinler S E, et al. Mutational inactivation of transforming growth factor TGF-β receptor type Ⅱ in microsatellite stable colon cancers[J]. Cancer Res, 1999, 59(2): 320-324.
  • 7Goggins M. , Shekher M, Turnacioglu K, et al. Genetic alterations of the transforming growth factor-(receptor genes in pancteafic and biliary adenocarcinomas[J]. Cancer Res, 1998, 58(23): 5329-5332.
  • 8Kang SH, Bang YJ, Im YH, et al. Transcriptional repression of the transforming growth factor type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer[J]. Oncogene, 1999, 18(51): 7280-7286.
  • 9Kleeff J, Ishiwata T, Maruyana H, et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer[J]. Oncogene, 1999, 18(39): 5363-5372.
  • 10Hu W , Wu W, Nash MA, et al. Anomalies of TGF-beta postreceptor signaling pathway in ovarian cancer cell line[J]. Anticancer Res, 2000, 20(2A): 729-733.

共引文献16

同被引文献78

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部